Fetal Bovine Serum for Cell Culture Media Market

Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS

Fetal Bovine Serum for Cell Culture Media Market contains market size and forecasts of Fetal Bovine Serum for Cell Culture Media in global, including the following market information:

Global Fetal Bovine Serum for Cell Culture Media Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Fetal Bovine Serum for Cell Culture Media Market Sales, 2017-2022, 2023-2028, (K Liters)

Global top five Fetal Bovine Serum for Cell Culture Media companies in 2021 (%)

The global Fetal Bovine Serum for Cell Culture Media market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

North America-sourced Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fetal Bovine Serum for Cell Culture Media include Thermo Fisher, Cytiva, Merck, Moregate BioTech, Gemini, R&D Systems, Tissue Culture Biologicals, Bovogen and Biowest, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

surveyed the Fetal Bovine Serum for Cell Culture Media manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fetal Bovine Serum for Cell Culture Media Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Liters)

Global Fetal Bovine Serum for Cell Culture Media Market Segment Percentages, by Type, 2021 (%)

North America-sourced

South America-sourced

Australia-sourced

Others

Global Fetal Bovine Serum for Cell Culture Media Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Liters)

Global Fetal Bovine Serum for Cell Culture Media Market Segment Percentages, by Application, 2021 (%)

Academic Research

Commercial Research

Global Fetal Bovine Serum for Cell Culture Media Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Liters)

Global Fetal Bovine Serum for Cell Culture Media Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fetal Bovine Serum for Cell Culture Media revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Fetal Bovine Serum for Cell Culture Media revenues share in global market, 2021 (%)

Key companies Fetal Bovine Serum for Cell Culture Media sales in global market, 2017-2022 (Estimated), (K Liters)

Key companies Fetal Bovine Serum for Cell Culture Media sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Thermo Fisher

Cytiva

Merck

Moregate BioTech

Gemini

R&D Systems

Tissue Culture Biologicals

Bovogen

Biowest

Internegocios

RMBIO

Biological Industries

PAN-Biotech